Copyright Reports & Markets. All rights reserved.

Global Adult and Pediatric Vaccines Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Adult and Pediatric Vaccines Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Adult Vaccines
      • 1.4.3 Pediatric Vaccines
    • 1.5 Market by Application
      • 1.5.1 Global Adult and Pediatric Vaccines Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Medical Care Centers
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Adult and Pediatric Vaccines Market Size
    • 2.2 Adult and Pediatric Vaccines Growth Trends by Regions
      • 2.2.1 Adult and Pediatric Vaccines Market Size by Regions (2014-2025)
      • 2.2.2 Adult and Pediatric Vaccines Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Adult and Pediatric Vaccines Market Size by Manufacturers
      • 3.1.1 Global Adult and Pediatric Vaccines Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Adult and Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.2 Adult and Pediatric Vaccines Key Players Head office and Area Served
    • 3.3 Key Players Adult and Pediatric Vaccines Product/Solution/Service
    • 3.4 Date of Enter into Adult and Pediatric Vaccines Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Adult and Pediatric Vaccines Market Size by Type (2014-2019)
    • 4.2 Global Adult and Pediatric Vaccines Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Adult and Pediatric Vaccines Market Size (2014-2019)
    • 5.2 Adult and Pediatric Vaccines Key Players in United States
    • 5.3 United States Adult and Pediatric Vaccines Market Size by Type
    • 5.4 United States Adult and Pediatric Vaccines Market Size by Application

    6 Europe

    • 6.1 Europe Adult and Pediatric Vaccines Market Size (2014-2019)
    • 6.2 Adult and Pediatric Vaccines Key Players in Europe
    • 6.3 Europe Adult and Pediatric Vaccines Market Size by Type
    • 6.4 Europe Adult and Pediatric Vaccines Market Size by Application

    7 China

    • 7.1 China Adult and Pediatric Vaccines Market Size (2014-2019)
    • 7.2 Adult and Pediatric Vaccines Key Players in China
    • 7.3 China Adult and Pediatric Vaccines Market Size by Type
    • 7.4 China Adult and Pediatric Vaccines Market Size by Application

    8 Japan

    • 8.1 Japan Adult and Pediatric Vaccines Market Size (2014-2019)
    • 8.2 Adult and Pediatric Vaccines Key Players in Japan
    • 8.3 Japan Adult and Pediatric Vaccines Market Size by Type
    • 8.4 Japan Adult and Pediatric Vaccines Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Adult and Pediatric Vaccines Market Size (2014-2019)
    • 9.2 Adult and Pediatric Vaccines Key Players in Southeast Asia
    • 9.3 Southeast Asia Adult and Pediatric Vaccines Market Size by Type
    • 9.4 Southeast Asia Adult and Pediatric Vaccines Market Size by Application

    10 India

    • 10.1 India Adult and Pediatric Vaccines Market Size (2014-2019)
    • 10.2 Adult and Pediatric Vaccines Key Players in India
    • 10.3 India Adult and Pediatric Vaccines Market Size by Type
    • 10.4 India Adult and Pediatric Vaccines Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Adult and Pediatric Vaccines Market Size (2014-2019)
    • 11.2 Adult and Pediatric Vaccines Key Players in Central & South America
    • 11.3 Central & South America Adult and Pediatric Vaccines Market Size by Type
    • 11.4 Central & South America Adult and Pediatric Vaccines Market Size by Application

    12 International Players Profiles

    • 12.1 GlaxoSmithKline
      • 12.1.1 GlaxoSmithKline Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Adult and Pediatric Vaccines Introduction
      • 12.1.4 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.1.5 GlaxoSmithKline Recent Development
    • 12.2 Sanofi
      • 12.2.1 Sanofi Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Adult and Pediatric Vaccines Introduction
      • 12.2.4 Sanofi Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.2.5 Sanofi Recent Development
    • 12.3 Merck
      • 12.3.1 Merck Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Adult and Pediatric Vaccines Introduction
      • 12.3.4 Merck Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.3.5 Merck Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Adult and Pediatric Vaccines Introduction
      • 12.4.4 Novartis Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 Pfizer
      • 12.5.1 Pfizer Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Adult and Pediatric Vaccines Introduction
      • 12.5.4 Pfizer Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.5.5 Pfizer Recent Development
    • 12.6 AstraZeneca
      • 12.6.1 AstraZeneca Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Adult and Pediatric Vaccines Introduction
      • 12.6.4 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.6.5 AstraZeneca Recent Development
    • 12.7 Johnson and Johnson
      • 12.7.1 Johnson and Johnson Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Adult and Pediatric Vaccines Introduction
      • 12.7.4 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.7.5 Johnson and Johnson Recent Development
    • 12.8 Takeda Pharmaceutical
      • 12.8.1 Takeda Pharmaceutical Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Adult and Pediatric Vaccines Introduction
      • 12.8.4 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.8.5 Takeda Pharmaceutical Recent Development
    • 12.9 Bavarian Nordic
      • 12.9.1 Bavarian Nordic Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Adult and Pediatric Vaccines Introduction
      • 12.9.4 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.9.5 Bavarian Nordic Recent Development
    • 12.10 LG Life Sciences
      • 12.10.1 LG Life Sciences Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Adult and Pediatric Vaccines Introduction
      • 12.10.4 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2014-2019)
      • 12.10.5 LG Life Sciences Recent Development
    • 12.11 Sinovac Biotech

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
      In 2018, the global Adult and Pediatric Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Adult and Pediatric Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adult and Pediatric Vaccines development in United States, Europe and China.

      The key players covered in this study
      GlaxoSmithKline
      Sanofi
      Merck
      Novartis
      Pfizer
      AstraZeneca
      Johnson and Johnson
      Takeda Pharmaceutical
      Bavarian Nordic
      LG Life Sciences
      Sinovac Biotech

      Market segment by Type, the product can be split into
      Adult Vaccines
      Pediatric Vaccines

      Market segment by Application, split into
      Hospitals
      Medical Care Centers
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Adult and Pediatric Vaccines status, future forecast, growth opportunity, key market and key players.
      To present the Adult and Pediatric Vaccines development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Adult and Pediatric Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now